MedPath

Effectiveness of Unified Protocol in Anxiety Disorders

Not Applicable
Conditions
Health Condition 1: F400- AgoraphobiaHealth Condition 2: F411- Generalized anxiety disorderHealth Condition 3: F413- Other mixed anxiety disordersHealth Condition 4: F418- Other specified anxiety disordersHealth Condition 5: F410- Panic disorder [episodic paroxysmal anxiety]Health Condition 6: F401- Social phobias
Registration Number
CTRI/2021/01/030803
Lead Sponsor
niversity Grants Commission
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients diagnosed with a primary diagnosis of anxiety disorder according to DSM-V

People who consent for the baseline phase

Patients who can comprehend and be conversant in English, Tamil or Malayalam

Stabilized on medication 4 weeks prior to the beginning of the therapy

Exclusion Criteria

Primary diagnosis of schizophrenia, bipolar affective disorder, patients with suicidal risk, co-morbid severe depression with or without psychotic symptoms and clinical evidence for intellectual disability, or other neurological, neurosurgical or organic conditions that may interfere with engagement in therapy

Current use of psychoactive substance in dependence pattern except nicotine dependence

Primary diagnosis of depression with secondary anxiety symptoms

Patients who have undergone structured psychotherapeutic intervention of 8 or more sessions will be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath